Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-084860
Filing Date
2013-11-14
Accepted
2013-11-14 16:45:54
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19293_110q.htm 10-Q 726267
2 EX-10.1 a13-19293_1ex10d1.htm EX-10.1 319087
3 EX-10.2 a13-19293_1ex10d2.htm EX-10.2 28479
4 EX-31.1 a13-19293_1ex31d1.htm EX-31.1 11197
5 EX-31.2 a13-19293_1ex31d2.htm EX-31.2 10737
6 EX-32.1 a13-19293_1ex32d1.htm EX-32.1 7291
  Complete submission text file 0001104659-13-084860.txt   6284670

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT path-20130930.xml EX-101.INS 456747
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT path-20130930.xsd EX-101.SCH 84081
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT path-20130930_cal.xml EX-101.CAL 37288
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT path-20130930_lab.xml EX-101.LAB 1332011
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT path-20130930_pre.xml EX-101.PRE 600804
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT path-20130930_def.xml EX-101.DEF 378967
Mailing Address 7 GREAT VALLEY PARKWAY SUITE 300 MALVERN PA 19355
Business Address 7 GREAT VALLEY PARKWAY SUITE 300 MALVERN PA 19355 610-232-0800
NUPATHE INC. (Filer) CIK: 0001375200 (see all company filings)

EIN.: 202218246 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34836 | Film No.: 131220836
SIC: 2834 Pharmaceutical Preparations